Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
OH OK. Thanks I'll do that.
I don't have twitter..... The removal of the post referring to the EAPH tweet & picture makes me suspicious that a tweet actually exists. Thanks.
What happened to the the post either 43539 or 43540 stating that a tweet by EAPH with a picture at the product launch existed? Why was it removed? I guess the tweet doesn't exist or I'm looking in the wrong place. Can someone clarify, Mck or one of the 007 posters? THanks
It's not anymore stupider than yahoo's here saying EAPH is going to the moon!
I thought my comment was quite funny based on EAPH's history of smoke and miorrors.You're entitled to ur opinion, pal as am I. Until we see some actual/verifiable revenue I'm skeptical EAPH is a P andD period. By verifiable I do not mean EAPH tells us they have received revenue. If you don't appreciate my humor put me on ignore, hahaha....
We did not forget. We just wonder if EAPH remembers or will we receive a tweet that they were unable to launch due to the time change or maybe they could not fly over the USA due to travel restictions for aliens.! Darn Trump..... Yea let's blame him.
How do you know hahaha! You and the other .....007 seem to know everything LOL
Maybe I missed it but has anything been published about yesterday's meeting in NYC? Maybe a another time change problem, eh. I'm concerned If we don't see a PR about yesterday's meeting this stock will sink like a rock today.
BS smart Alex
Exactly. I agree with you but these big companies were not recent P&D's
Sure first without details the PR has no credibility.
Exactly. EAPH needs to shed their previous P&D image. An excellent way to do this is to become more factual in PR's & tweets. At this stage in the company's development vague comments like they have PO, advance Pmt etc without some pertinent detail lend themselves to mistrust. For example , we received an initial PO for 500000 units of product X to be used in tge initial rollout in Mexican beginning in mid February,2017 & also we received a down payment of X%. IMO this type of stmt adds creditability to EAPH's supposedly informative comments.
Windsor lost out to Gedeon Richter. Aren't we suppose to see sales in February?
People are holding their breath making sure this surge is real.
Right now I'd like to see $0.198
A year or so ago
100% agree
Inaccurate comment. PR said ibliss projects $15000000 Revenue. You're the one stating ibliss already has $15000000. Please stop your misleading comments & try to stick to the facts.
And you know this how?
It really doesn't matter abt facts. Your comments should make the stock price of EAPH rise for my tax purposes.
Its an exact repost word for word from 2015.
Ah yes. Thanks.
Who tells you all these secrets and why do they tell you?
No a PO does not mean that any money has been exchanged. It only means, if it exists, that someone/company ordered product to be shipped at some date. Sales are not usually booked or recorded by the shipping company until the product is shipped as required by GAAP. Once the PO issuer receives the product and invoice from the shipping company payment is then submitted under the terms of the PO,ie, 2% discount for payment in 30 days etc....
Easton only receives money when they ship, invoice and receive payment from customer, not when they receive a Purchase Order. Where did you study Accounting? It;s possible Easton may have received a downpayment but there was no mention about that in the infamous PO, PR. As we all know no details were given about the PO other than one was supposedly received.
Is this the same news as you posted ? I guess he was reappointed, eh. Funny, one was dated August 17,2015 and the other Jan 20,2017. I don't remember when was Evan Karras appointed CEO Of Easton Pharmaceuticals?
SOURCE: Easton Pharmaceuticals Inc
Easton Pharmaceuticals Inc
August 17, 2015 08:43 ET
Easton Pharmaceuticals Announces Major Initiative Supporting Its Focus on Unique Patented Women's Health Products With the Appointment of Dr. Jose Tiran as Founding Member of Easton's Medical/Scientific Advisory Board in Women's Health
TORONTO, ON--(Marketwired - Aug 17, 2015) - Easton Pharmaceuticals Inc. (OTC PINK: EAPH), in parallel with Easton's focus on Women's Health, Easton is pleased to announce the appointment of Dr. Jose Tiran Saucedo as the Founding Member of Easton Pharma's Medical/ Scientific Advisory Board. In this capacity, Dr. Tiran will advise Easton Pharmaceuticals and its partner BMV Medica in planning the Latin American launches of its suite of patented, exclusive women's health products over the coming months.
Dr. Jose Tiran is a Thought Leader (KOL - Key Opinion Leader) in Gynecological Infectious Diseases, and is a Fellow of the American College of Obstetricians and Gynecologists. He has been a strong advocate over the years in women's health worldwide. Also, Dr. Tiran has published numerous peer-reviewed papers on the subject, and is also board certified in Mexico, a member of multiple health societies, and holds numerous other prestigious positions in the field of Women's Health. Dr. Tiran is also well versed in other aspects of women's health such as sexually transmitted diseases, female sexual health, contraception, vaccines and gynecology and women´s health and wellbeing.
Dr. Tiran stated, "I am very excited to be part of the program for these soon-to-be-launched women's health and treatment products in the hope of providing to Latin American women the same choices they have in the US and Europe. We have a huge unmet medical need in Latin America for these kind of alternative diagnostic and treatment products. The vaginal discharge diagnostic test will facilitate a woman's ability to determine the causative agent; the natural lactic acid treatment gel will provide a new, non-toxic treatment option, and put Latin American women on a par with North American and European women. The professional version of this diagnostic test will also enable the gynecologist to increase the accuracy in the differential diagnosis of vaginal discharge, right in the gynecologist's office, something currently lacking in Latin America. The natural lactic acid gel treatment expected to launch in parallel with the diagnostic will be offered to women who test positive for bacterial infection and is a significant treatment option advance since it could obviate the need for potential use of antibiotics and further presence of bacterial resistance, so this is a promising and exciting development for the future of women's health."
Dr. Tiran further commented, "The amniotic fluid leak test will allow late-pregnancy women to have at their disposal a high-specificity/accuracy test at a fractional cost to other options on the market, with a very favorable ease-of-use component, thus contributing to an increase in the quality of perinatal care in Latin America. All these are new advances coming to Latin America, which I believe will catch on very quickly in both the community and the professional arenas."
Evan Karras, CEO Of Easton Pharmaceuticals, stated, "We are extremely pleased to have retained the services and brought to Easton, someone with the quality and industry leading respect that Dr. Tiran holds. His status in the industry will no doubt assist in leading Easton to have its product lines well established resulting in sales success in the Mexican and Latin American Markets for both professional and consumer use." Mr. Karras further commented, "The announcement of Dr. Tiran is a big leap with attaining industry leading credibility towards our goal of having all products approved and ready for launch by the end of 2015."
About Easton Pharmaceuticals
Easton Pharmaceuticals is a diversified specialty pharmaceutical company involved in various pharmaceutical sectors and other growing industries such as medical marijuana. The Company previously developed and owned an FDA approved wound-healing drug and currently owns topically delivered drugs to treat cancer and other conditions that are all in various stages of development and approval. Easton has entered into a 50 / 50 revenue sharing agreement towards being the exclusive distributor in Mexico and Latin America for patented women's diagnostic products and two generic cancer products. Easton has completed an acquisition that grants 40% ownership interest in Medicated Markets International LLC; a company holding Medical Marijuana growing rights in California on 20 acres (3 acre growing area). Easton has also made additional investments into AMFIL Technologies, a company who own rights to a product called the groZONE anti-microbial airflow system and hold an exclusive option to purchase up to 49% in a (MMPR) medical marijuana grow-op business post granting of license from Health Canada in Ontario, which has received a letter to build from Health Canada. The company's gel formulation is thought to be an innovative and unique transdermal delivery system that can in the future be adaptable in the delivery of other drugs and Cannabidiol extracts.
For More Information Visit:
http://www.eastonpharmaceuticalsinc.com
http://ecigmarkets.com
http://finance.yahoo.com/q?s=eaph
https://twitter.com/eastonpharma
Safe Harbor
This news release may contain forward-looking statements or expressions within the meaning of the Private Securities Litigation Reform Act of 1995 (The "Act"). In particular, when certain words or phrases such as "hope", "positive", "anticipate," "pleased," "plan," "confident that," "believe," "expect," "possible" or "intent to" and similar conditional expressions are expressed, they are intended to identify forward-looking statements within the meaning of the Act and are subject to the safe harbor created by the Act. Such statements are subject to certain risks and uncertainties and actual results could differ materially from those expressed in any of the forward-looking statements. Any investment made into Easton Pharmaceuticals would be classified as speculative and may contain risks. Such risks and uncertainties include, but are not limited to, market conditions, general acceptance of the company's products and technologies, competitive factors, the ability to successfully complete additional or adequate financing, government approvals or changes to proposed laws and other risks and uncertainties further stated in the company's financial reports and filings.
CONTACT INFORMATION
Contact:
Evan Karras
Nunzio Valerie Jr.
Tel: +1(416) 619-0291
Tel: +1(347) 284-0192
Email: info@eastonpharmaceuticalsinc.com
Right after the audit results are published/tweeted. BTW " soon" does not apply to the audit that has been ongoing for what 1-2 years to complete......
Me too. I bought this stock in May, 2014.I'm still waiting on SOON also, although I have recently broken even and up 10 % None of these soon guys will answer your comment 'dave 55' .
Finally MCK you have provided some detail and logic how you arrived at the conclusion that EAPH is in negotiations with AERO. I did not make that connection and it makes some sense to me now.. Thanks.
I trusted them at one time and have been under water ever since with their BS PR's and pumping by several posters. I have seen nothing verified as in NO AUDIT as promised by mgmt and heard their pie in the sky business plans for the last 2+ years. Certainly today's ambiguous PO from Gedeon Richter without quantities and $ amount ordered is the same fluff they have been spewing to sell their insider obtained shares. I'm not saying Gedeon Richter did not issue a PO, but a blank PO seems a bit farfetched for this Auditor of a fortune 500 company to believe. If somebody in my company issued a blank PO they would be fired/dismissed immediately.Maybe you don't understand that a PO is a legal binding contract between the two parties involved, and issuing a PO without quantity and $ amount allows the other party to fill in any number they want................. So the PO must be completed and then VERIFIED as to the terms of the agreement between the parties involved and then they can send out a PR indicating the details of: quantities, $'s ,delivery dates & payment terms etc....For all we know this PO could be for 100-200 samples to distribute to company salesmen
"... the business plan is solid and verified",with no numbers provided in the PR released today, LOL, How is that keeping the shareholders informed? We don't need an exact #, a ballpark figure will do. Would be nice to see a copy of the P.O. also. Better yet would be better to see a PR from Gedeon Richter. I don't trust these EAPH'ers.............
I don't understand the connection to EAPH, please explain. Thank you.
New Colombia Resources, Inc. (NEWC)
New Colombia Resources, Inc. engages in the acquisition, exploration, and development of metallurgical coal properties in Colombia. It holds a 100% interest in the La Tabaquera metallurgical coal mine in Colombia. The company was formerly known as VSUS Technologies Incorporated and changed its name to New Colombia Resources, Inc. in January 2013. New Colombia Resources, Inc. was incorporated in 2000 and is based in Barranquilla, Colombia.
Hi today ....$0.029899 so far
I think it will come back though as long as the events in progress come to fruition in the near future as indicated by the company. I'm excited though. In mid Oct I was 95% down, now I'm only 6.5% down.
Well it hit $0.0021 and now back to $0.0197. Hope it stays at these levels.
FYI
Platinum Partners arrests are scant consolation for alleged victims.
http://finance.yahoo.com/news/platinum-partners-arrests-scant-consolation-163022840.html
No. IHUB was down until 5 minutes ago for me.
tardelli007 please read my post# 40535/Rg
It appears that I owe you and tardelli007 an apology because there is an actual JV PR and apparently an agreement to commence business together in February 2017. Great find to the two of you. I don't know how you did it but the results should be great in the coming months and years./ Thanks,Rg
When did you see this buy rating? Was it before or after the tweet was deleted re; Pharma JV PR * other tweets changed.
Darn. I almost got my initial investment back. Probably go back to sub penny again before I can sell